相关实验视频

Updated: Jun 4, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

脂蛋白和冠状动脉疾病的预后之间的相关性在接受皮肤冠状动脉干预的患者中

Azhi ShaMa¹, Chunlan Ma¹, Yingying Huang¹

¹Department of Cardiology, Daping Hospital, The Third Military Medical University (Army Medical University), Chongqing, People's Republic of China.

Texas Heart Institute journal

|December 18, 2024

概括

升高的脂蛋白 (Lp[a]) 不会增加在皮肤穿透冠状动脉干预后冠状动脉疾病的患者内置静脉缩或重复手术的风险. 这一发现对于理解二次预防中的Lp (a) 非常重要.

科学领域:

心脏病学心脏病学
临床研究临床研究
脂质代谢脂质代谢是什么

背景情况:

升高的脂蛋白 (Lp[a]) 是最初动脉样硬化事件的已知危险因素.
它在心血管疾病的二次预防中的作用仍然存在争议.
这项研究调查了Lp (a) 在已确诊冠状动脉疾病的患者中.

研究的目的:

追溯分析升高Lp (a) 水平对冠状动脉疾病患者预后的影响.
评估Lp(a) 与皮肤穿透冠状动脉干预 (PCI) 后的结果之间的关联.

主要方法:

在PCI期间住院的患者的临床数据的回顾性分析.
使用多变量逻辑回归来评估Lp,风险因素和预后之间的关系.
结局是在PCI后一年通过冠状动脉血管学评估的.

主要成果:

在基线特征或心血管风险因素中没有观察到Lp (a) 组之间的显著差异.
在一年的他类药物治疗后,Lp (a) 水平没有显著下降.
在PCI后一年,高Lp (a) 水平并没有显著增加静脉缩或二次PCI的发病率.

结论:

持续高的脂蛋白水平似乎不会显著提高冠状动脉疾病患者的内置静止症的风险或二次PCI的需要.
这些发现表明Lp (a) 可能不是PCI后二次心血管预防中不良结果的显著预测因素.

关键词:

冠状动脉疾病是一种冠状动脉疾病.冠状动脉静脉复缩症冠状动脉静脉复缩症脂蛋白 (a) 是一种蛋白质通过皮肤进行冠状动脉干预.

更多相关视频

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

相关概念视频

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...